Archives of the
Turkish Society of Cardiology
Invited review - General

ARISTOTLE study and sub-group analyses: Conspicuous points


Dokuz Eylül Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, İzmir

Archives of the Turkish Society of Cardiology 2016; 44: Supplement 14-25
Read: 362 Downloads: 91 Published: 01 July 2021

Aristotle study is a phase III study which evaluates apixaban’s safety and efficacy as comparing to warfarin in patients with nonvalvular AF (NVAF) having at least one stroke risk factor of apixaban. 18.201 patients were evaluated in this randomized, controlled, multicentered study. This review will overview of the Aristotle study and subgroup analysis.

ISSN 1016-5169 EISSN 1308-4488